169 One month results of trans-femoral Edwards Sapien aortic valve implantation performed under local anesthesia and exclusive fluoroscopy guidance in a single center  by Eltchaninoff, Hélène et al.





Archives of Cardiovascular Diseases Supplements (2010) 2, 50-60
 
associated with LV dysfunction and patient outcome. Left atrial (LA) enlarge-
ment is a surrogate marker of diastolic burden and a predictor of outcome.
Whether LA function might be affected by elevated global LV afterload has
never been examined. The aim of this study was thus undertaken to investigate
the impact of Zva on LA volume and function in severe AS.
 
Method and results: Tissue Doppler imaging and 2D transthoracic
echocardiography including measurements of LV and LA function and AS
assessment was performed in 39 consecutive patients (63% of male, 70±13
years) with an aortic valve area < 1cm2. Zva was calculated by dividing the
estimated LV systolic pressure (systolic arterial pressure + aortic mean
transvalvular gradient) by the LV stroke volume index. Patients were
studied in 2 groups according to Zva (median = 4.7ml/mmHg/m2). Although
patients with Zva ≥ 4.7 had higher LV mass (178±47 vs. 143±33 g/m2,
p=0.03), there was no significant difference between the 2 groups regarding
LV volume and function. By contrast, patients with a Zva ≥ 4.7 had lower
LA ejection fraction (42±13 vs. 53±10%, p=0.02), LA passive function
(18±8 vs. 26±10%, p=0.03) and LA conduit volume (19±21 vs. 47±24ml,
p=0.0012) compared to those with a low Zva. Late annular diastolic velocity
(Aa) was significantly lower in patients with a Zva ≥ 4.7 (7.1±3 vs. 9.2±3
cm/s, p=0.04), suggesting impaired LA active function. There are significant
correlations between Zva and Aa (r=–0.62, p=0.0002), LA ejection fraction
(r=–0.41, p=0.018), LA passive (r=–0.39, p=0.03) and LA conduit volume
(r=–0.71, p<0.0001).
Conclusion: In patients with severe AS, global LV afterload had signifi-
cant impact on LA ejection fraction and on LA active, passive and conduit
functions. Further studies are needed to evaluate the prognostic impact of LA
dysfunction in AS.
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Background: Carcinoid heart disease (CHD = valvular heart disease),
may occur in patients presenting with digestive endocrine tumor and carci-
noid syndrome. The most frequent presentation of CHD is a right-sided
CHD and may be associated with right ventricular (RV) enlargement.
Velocity vector imaging (VVI) is a new echocardiographic technology that
measures myocardial velocity and deformation using 2D speckle tracking.
The aim of this study was to compare the pattern of VVI in pts with CHD
and in healthy pts.
Methods: We prospectively studied 60 pts divided in 2 groups: 30 pts
with CHD (group 1) and an age- and sex-matched control group (n=30,
group 2). All pts with CHD had histologically proven digestive endocrine
tumor and carcinoid syndrome. Quantification of CHD severity was per-
formed according to a previous validated scoring system (score between 0
and 20). We systematically performed transthoracic echocardiography, with
the use of VVI technology, allowing to measure systolic peak velocity (V),
peak strain (S) and peak strain rate (SR) in basal, mid and apical right ven-
tricular free wall in apical 4-chamber view. RV systolic function was also
assessed by the RV fractional area change (FAC) measured in apical 4-
chamber view.
Results: Values of V, S and SR in basal, mid and apical RV free wall
(FW) were significantly lower in group 1 as compared to control group
(p<0.02 for basal FW and p<0.01 for mid and apical FW). Mean CHD score
of severity was 10.7 ± 4.6. In patients with lowest tertile of CHD score, no
significant difference occurred between group 1 and group 2, concerning
global values of V, S and SR, whereas patients with highest tertile of CHD
score presented with the most important RV systolic dysfunction. Strong
correlation was found between CHD score of severity and global values of
V (r=0.90, p<0.0001), whereas correlation between CHD score and FAC was
weak (r=0.42, p=0.04).
Conclusion: Our study suggests that VVI could be of interest in patients
with CHD, allowing to quantify RV systolic function. RV dysfunction in CHD
is related to the degree of valvular severity.
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Background: Percutaneous aortic valve replacement (PAVR) emerged in
2002 as a therapeutic alternative for patients (Pts) with severe symptomatic
aortic stenosis (AS) who are poor candidates for surgical aortic valve replace-
ment. More than 4000 Pts have been treated worldwide with the balloon
expandable Edwards valve. General anesthesia and TEE guidance are used in
the majority of centers.
Objective: To evaluate the early results and 30-day outcome of Pts with
severe AS treated by trans-femoral (TF) Edwards Sapien PAVR using a sim-
plified technique.
Methods: 61 Pts with severe symptomatic AS were included in our center
from April, 2006 to March, 2009 as part of the REVIVE and PARTNER mul-
ticentric trials and post-marketing SOURCE registry. All procedures were per-
formed under local anesthesia and sedation, without TEE guidance. Femoral
artery was cutdown and sutured surgically at the end of the procedure. Implan-
tation was performed under rapid pacing using calcifications on fluoroscopy
for valve positioning. All Pts had clinical and echographic follow-up at one-
day, one week, and one month.
Results: Mean age was 83.3 + 6.0 years and 47% were female. Logistic
Euroscore was 30 + 10%. A 23-mm or 26-mm valve was implanted in 40%
and 60% of Pts respectively. Mean aortic valve area (AVA) increased from
0.65 + 0.14 to 1.86 + 0.25 cm2 and mean gradient decreased from 40.4 + 15.6
mm Hg to 8.8 + 3.7 mm Hg. There was no valve embolization. There were 2
procedural deaths (3.2%): iliac artery rupture and aortic rupture during predi-
latation. There was no stroke and grade 3 aortic regurgitation was noted in 5%.
One Pt had tamponade. Two Pts required permanent pacing (3.2%). Overall
30-day mortality was 8.1%.
Conclusion: Edwards Sapien aortic valve implantation using surgical cut-
down under local anesthesia and fluoroscopy guidance for accurate valve posi-
tioning appears safe in our experience. The rate of vascular complication is
remarkably low (1.6%) using surgical cutdown and closure.
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Introduction: In organic mitral regurgitation (OMR), brain natriuretic
peptide (BNP) may be used as a surrogate marker of MR consequences on LV.
The use of tissue Doppler imaging (TDI) and 2-D speckle-tracking (2DSt) to
assess longitudinal strain improve the detection of subclinical LV dysfunction.
However, whether decreased long-axis function is a determinant of BNP has
never been examined.
Method and results: Transthoracic echocardiography including Dop-
pler, TDI and 2DSt quantification were performed in 56 consecutive
patients (61±15 years, 54% of male) with moderate to severe OMR. Peak
annulus velocity and time-to-peak velocity (TP) were measured using TDI
for Ea-, Aa- and Sa-wave. 2DSt was used to evaluate global longitudinal
strain (GLS). Simultaneously to echocardiography, blood sample was
drawn and plasma BNP level was measured. Patients were separated into
2 groups according to the median of BNP level (≥26pg/ml). Patients with
BNP ≥26pg/ml were significantly older (65±13 vs. 56±16 yrs, p=0.03) and
had higher LV systolic diameter (37±5 vs. 33±7mm, p=0.03), lower GLS
(19±4 vs. 22±3%, p=0.0016) and slower TP-Ea (480±49 vs. 456±45ms,
p=0.03). By contrast, there was no significant difference between the 2
groups with regard to LV volume and ejection fraction and MR severity.
Plasma BNP was correlated with age (r=0.29, p=0.04), LV systolic diam-
